Clinical Research Directory
Browse clinical research sites, groups, and studies.
Expanded Indications in the Pediatric BONEBRIDGE Population
Sponsor: Med-El Corporation
Summary
This study will assess safety and efficacy of the MED-EL BONEBRIDGE Bone Conduction Implant in children under 12 years old with conductive or mixed hearing loss.
Key Details
Gender
All
Age Range
3 Years - 12 Years
Study Type
INTERVENTIONAL
Enrollment
36
Start Date
2023-10-03
Completion Date
2026-07
Last Updated
2025-09-24
Healthy Volunteers
No
Interventions
MED-EL BONEBRIDGE Bone Conduction Implant
Subjects will be implanted with the MED-EL BONEBRIDGE Bone Conduction Implant System. Subjects will be fit with the appropriate external audio sound processor.
Locations (6)
University of Colorado Health/Children's Hospital of Colorado
Aurora, Colorado, United States
University of Miami
Miami, Florida, United States
University Hospital Newark/Rutgers New Jersey Medical School
Newark, New Jersey, United States
University of North Carolina
Chapel Hill, North Carolina, United States
The Ohio State University/Nationwide Children's Hospital
Columbus, Ohio, United States
University of Utah Health/Primary Children's Hospital
Salt Lake City, Utah, United States